Stock Graphs and Charts

This is a complete list of financial data submitted by Aevi Genomic Medicine, Inc. to the Securities and Exchange Commission (SEC) in their recent 10K and 10Q filings. These terms are taken from the XBRL portion of the filings.

Click on a term to see historical data and generate a time series chart from the historical filings.

Term
Accounting For Uncertainty In Income Taxes Second Step Minimum Percentage Likelihood That Benefit Will Berealized
Accounting For Uncertainty In Income Taxes Second Step Minimum Percentage Likelihood That Benefit Will Be Realized
Accounts Payable And Accrued Liabilities Current
Accounts Payable Trade Current
Accounts Receivable And Prepaid Expenses Current
Accrued Liabilities And Other Liabilities
Accrued Severance Cost Net
Accrued Severance Pay
Accrued Severance Pay Noncurrent
Accumulated Depreciation Associated With Impairment Of Assets
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Additional Paid In Capital Common Stock
Adjustment For Amortization
Adjustments To Additional Paid In Capital Common Stock Issued For Consultant
Adjustments To Additional Paid In Capital Cumulative Effect Of Reclassification Of Warrants From Equity To Liability Due To Application Of Asc
Adjustments To Additional Paid In Capital Deferred Stock Compensation
Adjustments To Additional Paid In Capital Dividend In Respect Of Reduction In Exercise Price Of Certain Warrants
Adjustments To Additional Paid In Capital In Issuance Of Warrants To Consultants
Adjustments To Additional Paid In Capital In Issuance Of Warrants To Consultants In September
Adjustments To Additional Paid In Capital Sharebased Compensation Options And Warrants Granted To Consultantsdiractors And Employees
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Adjustments To Additional Paid In Capital Stock Based Compensation Expense Related To Options To Consultants
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
Adjustments To Additional Paid In Capital Stock Split Effected As Stock Dividend
Allocated Share Based Compensation Expense
Amortization Of Deferred Stock Compensation
Amount Paid For Remaining Term Of Lease
Annual Maintenance Fees
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Assets
Assets Current
Assets Noncurrent
Bank Charges
Bank Deposits Pledged As Collateral
Capital Expenditures Incurred But Not Yet Paid
Cash And Cash Equivalents At Carrying Value
Cash And Cash Equivalents Period Increase Decrease
Classification Of Liability In Respect Of Warrants Into Equity Due To Exercise Of Warrants
Classification Of Liability In Respect Of Warrants To Additional Paid In Capital
Class Of Option Or Right Exercise Price Of Securities
Class Of Warrant Or Right Aggregate Exercise Price Of Securities
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Cashless Excercise Method
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Cashless Exercise Method
Class Of Warrant Or Right Expired
Class Of Warrant Or Right Liability At Equity Due Exercise Of Warrants
Class Of Warrant Or Right Liability At Equity Due Exercise Of Warrants Period Increase Decrease
Class Of Warrant Or Right Liability At Fair Value Period Increase Decrease
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Maximum
Class Of Warrant Or Right Publicly Traded
Class Of Warrant Or Right Publicly Traded Exercise Price
Class Of Warrant Or Right Transferred By Gift
Class Of Warrant Or Right Transferred By Gift Exercise Price
Common Shares Outstanding
Common Stock And Warrants Issuance Costs
Common Stock And Warrants Issuance Costs One
Common Stock Closing Share Price
Common Stock Par Or Stated Value Per Share
Common Stock Placed In Stock Exchange
Common Stock Placed In Stock Exchange Price Per Share
Common Stock Shares Authorized
Common Stock Shares Issued
Common Stock Shares Outstanding
Common Stock Value
Convertible Debt Fair Value Current
Debt Instrument Convertible Beneficial Conversion Feature
Deferred Cost
Deferred Issuance Costs
Deferred Issuance Expenses
Deferred Tax Assets Allowances And Reserves
Deferred Tax Assets Gross
Deferred Tax Assets Net
Deferred Tax Assets Operating Loss Carryforwards
Deferred Tax Assets Operating Loss Carryforwards Domestic
Deferred Tax Assets Operating Loss Carryforwards State And Local
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
Deferred Tax Assets Valuation Allowance
Deposit Assets
Depreciation
Derivative Gain Loss On Derivative Net
Derivative Liabilities Noncurrent
Development Stage Enterprise Deficit Accumulated During Development Stage
Dilutive Securities Effect On Basic Earnings Per Share Other
Director Compensation
Director Fees
Earnings Per Share Basic
Earnings Per Share Basic And Diluted
Earnings Per Share Diluted
Effective Income Tax Rate
Effective Income Tax Rate Continuing Operations
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
Effective Income Tax Rate Reconciliation At Increased Foreign Statutory Income Tax Rate
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
Effective Income Tax Rate Reconciliation Other Adjustments
Effective Income Tax Rate Reconciliation State And Local Income Taxes
Effective Income Tax Rate Reconciliation Tax Credits
Employee Related Liabilities Current
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Excess Amount Of Participation In Research And Development From Third Party
Excess Stock Shares Authorized
Exchange Differences Onlong Term Loan
Exchange Differences On Long Term Loan
Exchange Differences Onrestricted Lease Deposit
Exchange Differences On Restricted Lease Deposit
Expense Related Other Offering Costs
Expense Related To Underwriting Discounts And Commissions
Fair Value Adjustment Of Warrants
Fair Value Assumptions Expected Dividend Rate
Fair Value Assumptions Expected Volatility Rate
Fair Value Assumptions Risk Free Interest Rate
Fair Value Assumptions Suboptimal Exercise Factor
Fair Value Of Class Of Warrant Or Right Liability
Financial Expenses
Financial Income
Financial Income Expense Net
Financing Interest Expense
Foreign Currency Exchange Rate Remeasurement Adjustment
Foreign Currency Remeasurement Adjustments
Fund Raising Expenses
Gain Loss On Disposition Of Assets1
Gain Loss On Disposition Of Property
General And Administrative Expense
Grant Based On Expenses Research And Development Expenses
Grants Receivable
Grants Received
Grants Received From Office Of Chief Scientist
Gross Proceeds Of Public Offering
Impairment Of Long Lived Assets Held For Use
Impairment Of Long Lived Assets To Be Disposed Of
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income Taxes Paid
Income Tax Expense Benefit
Income Tax Loss Carryforwards Percentage
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
Increase Decrease In Accounts Payable Trade
Increase Decrease In Accounts Receivable And Prepaid Expenses
Increase Decrease In Accounts Receivable Prepaid Expenses And Deferred Issuance Expenses
Increase Decrease In Other Accounts Payable Accrued Expenses And Advance Payment
Increase Decrease In Other Accounts Payable And Accrued Liabilities
Increase Decrease In Other Noncurrent Assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Increase Decrease In Restricted Lease Deposit
Increase Decrease In Restricted Lease Deposit And Prepaid Lease Payments
Increase In Restricted Lease Deposit
Increase In Restricted Lease Deposit And Prepaid Lease Payments
Incremental Common Shares Attributable To Call Options And Warrants
Interest And Amortization Of Beneficial Conversion Feature Of Convertible Note
Interest Expense
Interest Paid
Investment Income Interest
Issuance Expenses Paid With Shares
Issuance Of Common Stock And Warrants In December Maximum Unit Price
Issuance Of Common Stock And Warrants In December Minimum Unit Price
Issuance Of Common Stock And Warrants In January Unit Price
Issuance Of Common Stock And Warrants In May July And August Unit Price
Issuance Of Common Stock And Warrants New Issues In December Maximum Exercise Price
Issuance Of Commonstock And Warrants New Issues In December Minimum Exercise Price
Issuance Of Common Stock And Warrants New Issues In December Minimum Exercise Price
Issuance Of Common Stock And Warrants New Issues In January Exercise Price
Issuance Of Common Stock And Warrants New Issues In March April And June Exercise Price
Issuance Of Commonstock And Warrants New Issues In May July And August Exercise Price
Issuance Of Common Stock And Warrants New Issues In May July And August Exercise Price
Issuance Of Commonstock And Warrants New Issues In November And December Exercise Price
Issuance Of Common Stock And Warrants New Issues In November And December Exercise Price
Issuance Of Common Stock And Warrants To Consultants As Settlement Of Debt
Issuance Of Common Stock In Unit Price
Issuance Of Common Stock New Issues Consultant Excercise Price
Issuance Of Common Stock New Issues Consultants Fair Value
Issuance Of Common Stock New Issues Excercise Price
Issuance Of Common Stock New Issues Exercise Price
Issuance Of Common Stock New Issues In February Exercise Price
Issuance Of Common Stock New Issues In October Exercise Price
Issuance Of Commonstock New Issuesto Consultant Exercise Price
Issuance Of Common Stock New Issues To Consultant Exercise Price
Issuance Of Common Stock Price Per Commonstock
Issuance Of Common Stock Price Per Common Stock
Issuance Of Common Stock Price Per Share
Issuance Of Common Stock Price Per Share In March
Issuance Of Common Stock Price Per Share In March April And June
Issuance Of Common Stock Price Per Share In May One
Issuance Of Common Stock Price Per Share In May Two
Issuance Of Common Stock Price Per Unit In October
Issuance Of Common Stock To Consultant Fair Value
Issuance Of Common Stock To Consultant New Issues Exercise Price
Issuance Of Common Stock To Consultants Fair Value
Issuance Of Common Stock Unit Price Maximum
Issuance Of Common Stock Unit Price Minimum
Issuance Of Common Stock Upon Conversion Of Convertible Debentures
Issuance Of Convertible Debenture And Warrants
Issuance Of Preferred Stock New Issues In April And May Exercise Price
Issuance Of Preferred Stock New Issues In January Exercise Price
Issuance Of Preferred Stock New Issues In March And June Exercise Price
Issuance Of Preferred Stock New Issues In October Exercise Price
Issuance Of Preferred Stock Price Per Share In April And May
Issuance Of Preferred Stock Price Per Share In January
Issuance Of Preferred Stock Price Per Share In March And June
Issuance Of Preferred Stock Price Per Share In October
Issuance Of Price Per Units Each Unit Consisting Of One Common Stock And075 Warrant
Issuance Of Shares As Consideration For Providing Security For Letter Of Credit
Issuance Of Warrants In Unit
Issuance Of Warrants In Unit In December
Issuance Of Warrants In Unit In January
Issuance Of Warrants In Unit In March April And June
Issuance Of Warrants In Unit In May July And August
Issuance Of Warrants In Unit In November And December
Issuance Of Warrants New Issues Excercise Price
Issuance Of Warrants New Issues Exercise Price
Issuance Of Warrants New Issues Price Per Warrant
Issuance Of Warrants Price Per Share
Less Participation By Office Of Chief Scientist
Liabilities
Liabilities And Stockholders Equity
Liabilities Current
Liabilities Noncurrent
Long Term Assets
Long Term Lease Deposits
Market Price Shares
Minimum Qualifying Investment For Subsidiary
Net Cash Provided By Used In Financing Activities
Net Cash Provided By Used In Financing Activities Continuing Operations
Net Cash Provided By Used In Investing Activities
Net Cash Provided By Used In Investing Activities Continuing Operations
Net Cash Provided By Used In Operating Activities
Net Cash Provided By Used In Operating Activities Continuing Operations
Net Income Loss
Net Income Loss Attributable To Parent Diluted
Net Income Loss Available To Common Stockholders Basic
Net Proceeds From Issuance Initial Public Offering
New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
Non Cash Equity Based Remuneration
Non Recurring Research And Development Expense
Number Of Shares Purchased Upon Exercise Of Warrants
Number Of Warrants Consists Per Unit
Obligation To Issue Additional Shares To Consultants For Service Performed
Offering Costs
Officers Compensation
Operating Income Loss
Operating Leases Future Minimum Payments Due
Operating Leases Future Minimum Payments Due Current
Operating Leases Future Minimum Payments Due In One To Three Years
Operating Leases Future Minimum Payments Due In Three To Five Years
Operating Leases Future Minimum Payments Due Thereafter
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
Operating Loss Carry Forwards Subsidiary
Other Accounts Payable And Accrued Expenses Current
Other Accounts Payable And Accrued Liabilities
Other Assets Noncurrent
Other Finance Expense
Other Finance Income
Other Nonoperating Expense
Other Nonoperating Income
Other Nonoperating Income Expense
Other Research And Development Expense
Participation By Third Party
Paticipation Interest Receivable Third Party
Payments Of Common Stock And Warrant Issuance
Payments To Acquire Property Plant And Equipment
Percentage Of Tax Expense Benefit
Preferred Stock Issuance Costs
Preferred Stock Issuance Costs One
Preferred Stock Issued During Period Value New Issues In April And May
Preferred Stock Issued During Period Value New Issues In January
Preferred Stock Issued During Period Value New Issues In March And June
Preferred Stock Issued During Period Value New Issues In October
Prepaid Expense And Other Assets Current
Prepaid Expense Current
Proceeds From Bank Debt
Proceeds From Exercise Of Options And Warrants
Proceeds From Issuance Of Long Term Debt
Proceeds From Issuance Of Shares And Warrants
Proceeds From Issuance Of Shares And Warrants Net
Proceeds From Issuance Of Warrants
Proceeds From Issuance Of Warrants And Common Stock
Proceeds From Issuance Or Sale Of Equity
Proceeds From Sale Of Property Plant And Equipment
Proceeds From Warrants And Options Exercises
Proceeds Net Of Underwriting Discounts Commissions And Other Offering Costs
Property Plant And Equipment Gross
Property Plant And Equipment Net
Rate Of Royalties
Receipts On Account Of Stock In Respect To Exercise Of Warrants
Receipts On Account Of Stock In Respect To Exercise Of Warrants In January
Receivable From Government Authorities
Receivables From Exercise Of Options
Received From Office Of Chief Scientist
Repayments Of Long Term Debt
Research And Development Accrual Current
Research And Development Expense
Research And Development Expenses Gross
Research And Development Grants Receivable
Restricted Cash And Investments Noncurrent
Retained Earnings Accumulated Deficit
Severance Costs
Severance Costs1
Severance Expenses
Severance Pay Fund Noncurrent
Share Based Compensation
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandwarrantsforfeituresinperiodvalue
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Share Based Compensation Arrangement By Share Based Payment Award Options Granted To Directors And Employees
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Grants In Period Restrictions Removed Later
Share Based Compensation Arrangement By Share Based Payment Award Stock Grant In Period
Share Based Compensation Nonvested Awards Granted To Employees And Directors Unrecognized Compensation Cost
Share Based Compensation Number Of Shares Yet To Be Issued Included In Equity Compensation Value
Share Based Compensations
Shares Float
Shares Issued Price Per Share
Shares Issued Upon Excercise Of Class Of Warrant Or Right
Shares Issued Upon Excercise Of Class Of Warrant Or Right Cashless Excercise Method
Shares Issued Upon Exercise Of Class Of Warrant Or Right Cashless Exercise Method
Stock And Warrants Issued During Period Shares New Purchase
Stock Based Compensation Related To Options And Warrants Granted To Employees And Consultants
Stock Based Compensation Value Related To Issuance And Vesting Of Restricted Common Stock To Directors In January2012
Stock Based Consideration Related To Acquisition
Stockholders Equity
Stockholders Equity Note Stock Split Conversion Ratio
Stockholders Equity Stock Split Number Of Shares Eliminated
Stock Issued And Vested During Period Value Restricted Stock Award To Directors And Employee
Stock Issued During Period Shares Additional Issues To Consultants
Stock Issued During Period Shares New Issues For Consultant
Stock Issued During Period Shares New Issues To Consultants
Stock Issued During Period Shares Stock Options Exercised
Stock Issued During Period Value Conversion Into Common Stock
Stock Issued During Period Value Conversion In To Common Stock
Stock Issued During Period Value Conversion Of Convertible Notes
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
Stock Issued During Period Value Exercise Of Stock Options
Stock Issued During Period Value Exercise Of Warrants
Stock Issued During Period Value Exercise Of Warrants In December
Stock Issued During Period Value Exercise Of Warrants In January
Stock Issued During Period Value Exercise Of Warrants In January And February
Stock Issued During Period Value Issued For Services
Stock Issued During Period Value New Issues As Settlement Of Debt
Stock Issued During Period Value New Issues In August And September
Stock Issued During Period Value New Issues In February
Stock Issued During Period Value New Issues In March
Stock Issued During Period Value New Issues In October
Stock Issued During Period Value New Issues One In May
Stock Issued During Period Value New Issues To Consultant
Stock Issued During Period Value New Issues To Consultant In April
Stock Issued During Period Value New Issues To Consultant In August
Stock Issued During Period Value New Issues To Consultant In March And June
Stock Issued During Period Value New Issues To Consultants
Stock Issued During Period Value New Issues To Consultants In March And June
Stock Issued During Period Value New Issues To Consultants One
Stock Issued During Period Value New Issues To Director
Stock Issued During Period Value New Issues To Service Providers
Stock Issued During Period Value Newi Ssues Two In May
Stock Issued During Period Value New Issues Two In May
Stock Issued During Period Value Purchase Of Assets
Stock Issued During Period Value Restricted Stock
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
Stock Issued During Period Value Share Based Compensation To Consultants
Stock Issued During Period Value Stock
Stock Issued During Period Value Stock And Warrants
Stock Issued During Period Value Stock And Warrants In December
Stockissued During Period Valuestock And Warrants In January
Stock Issued During Period Value Stock And Warrants In January
Stock Issued During Period Value Stock And Warrants In June
Stock Issued During Period Value Stock And Warrants In March April And June
Stock Issued During Period Value Stock And Warrants In May July And August
Stock Issued During Period Value Stock And Warrants In November And December
Stock Issued During Period Value Stock Options And Warrants Exercised
Stock Issued During Period Value Stock Options Exercised And Warrants
Stock Issued During Period Value Warrants In September
Stock Issued During Period Value Warrants To Consultants
Stock Issued Related To Vesting Of Restricted Common Stock To Directors Value
Supplemental Unemployment Benefits Severance Benefits
Underwriting Discounts And Commissions
US Government Grant
Valuation Allowance Deferred Tax Asset Change In Amount
Valuation Of Convertible Debentures
Valuation Of Warrants
Warrant Liability
Warrants Exercised In Period
Warrants To Purchase Shares Of Common Stock
Warrant Valuation
Weighted Average Number Of Diluted Shares Outstanding
Weighted Average Number Of Share Outstanding Basic And Diluted
Weighted Average Number Of Shares Basic And Diluted Outstanding
Weighted Average Number Of Shares Outstanding Basic

Peers - Biological Products, Except Diagnostic Substances (Biotech) (2836)

Related News Stories

Aevi Genomic Medicine: Try Subgroups Until It Works?

2018-05-20 seekingalpha
Aevi's current strategy has a reasonable chance of success, but the stock has several red flags and remains highly speculative. (20-0)

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

2018-03-29 seekingalpha
The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this event. (16-1)